A new class of radiofibrosis drugs jointly developed by lijiexin pharmaceutical and Fujian Medical University
-
Last Update: 2014-09-26
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
At present, radiotherapy is the main treatment method for lung cancer, nasopharyngeal cancer and other tumors In his research, Professor Zhang Lulong found a kind of low toxic small molecular compound which has a clinical therapeutic prospect for radiation-induced pulmonary fibrosis, and obtained a patent It is reported that the successful listing of the drug will have great clinical significance for the prevention and treatment of pulmonary fibrosis in China and the world Fujian Mindong lijiexin Pharmaceutical Co., Ltd was founded in October 1997 by Beijing Academy of Military Medical Sciences with a registered capital of 15 million yuan The company has manufacturing center, R & D center, marketing center, financial center and administrative center The company has more than 300 employees, more than 40% of whom are technicians Among them, there is a postdoctoral of "hundred talents plan", a doctor of "thousand talents plan", 8 personnel with senior professional titles, 16 personnel with intermediate professional titles and 18 licensed pharmacists It is a modern pharmaceutical enterprise integrating science, industry, trade and research.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
